Literature DB >> 10330270

IL-7 receptor alpha+ CD3(-) cells in the embryonic intestine induces the organizing center of Peyer's patches.

H Yoshida1, K Honda, R Shinkura, S Adachi, S Nishikawa, K Maki, K Ikuta, S I Nishikawa.   

Abstract

Peyer's patch (PP) organogenesis proceeds through three histologically distinct steps: formation of organizing centers expressing VCAM-1 and ICAM-1 in segregated regions of the intestine at 15.5 days post-coitus (d.p.c.) (step I), accumulation of blood cells expressing different sets of surface markers to this region at 16.5-17.0 d.p.c. (step II), and entry of CD3+ and B220+ lymphocytes just before birth (step III). PP formation of both Il7ra-/- and Lta-/- mice is impaired from step I, suggesting involvement of the two molecules at the same timing in PP organogenesis. Expression of lymphotoxin (LT) alpha and LTbeta in IL-7 receptor (IL-7R) alpha+ cells in the intestine indicates that defects of Il7ra-/- and Lta-/- mice are due to functional inability of IL-7Ralpha+ cells in the induction of PP anlage. Blocking of IL-7Ralpha function by a single injection of the antagonistic mAb in 15.5 d.p.c. embryos suppressed appearance of VCAM-1(+) spots and expression of LTalpha and LTbeta in the intestine, which eventually resulted in mice without PP but are otherwise normal. Intestinal IL-7Ralpha+ cells are lymphoid in morphology but CD3(-) and functional in both nu/nu and Rag2-/- mice. These results implicate IL-7Ralpha+ CD3(-) cells as the direct inducer of the organizing center of PP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330270     DOI: 10.1093/intimm/11.5.643

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  81 in total

Review 1.  Role of the innate immune system in the development of chronic colitis.

Authors:  Takanori Kanai; Ryoichi Ilyama; Takahiro Ishikura; Koji Uraushihara; Teruji Totsuka; Motomi Yamazaki; Tetsuya Nakamuma; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

Review 2.  Establishment of intestinal homeostasis during the neonatal period.

Authors:  Silvia Stockinger; Mathias W Hornef; Cécilia Chassin
Journal:  Cell Mol Life Sci       Date:  2011-09-28       Impact factor: 9.261

3.  Role of lymphotoxin and homeostatic chemokines in the development and function of local lymphoid tissues in the respiratory tract.

Authors:  Javier Rangel-Moreno; Damian Carragher; Troy D Randall
Journal:  Inmunologia       Date:  2007

Review 4.  Lymphoid organogenesis in the intestine.

Authors:  Rebekah T Taylor; Ifor R Williams
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Heterogeneity of lymphoid tissue inducer cell populations present in embryonic and adult mouse lymphoid tissues.

Authors:  Mi-Yeon Kim; Simona Rossi; David Withers; Fiona McConnell; Kai-Michael Toellner; Fabrina Gaspal; Eric Jenkinson; Graham Anderson; Peter J L Lane
Journal:  Immunology       Date:  2008-01-16       Impact factor: 7.397

Review 6.  Induction of intestinal lymphoid tissue formation by intrinsic and extrinsic signals.

Authors:  Daniela Finke
Journal:  Semin Immunopathol       Date:  2009-06-09       Impact factor: 9.623

7.  Innate lymphoid cells in the defense against infections.

Authors:  Andreas Diefenbach
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-09-23

Review 8.  Development of secondary lymphoid organs.

Authors:  Troy D Randall; Damian M Carragher; Javier Rangel-Moreno
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

9.  Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells.

Authors:  Natasha K Crellin; Sara Trifari; Charles D Kaplan; Tom Cupedo; Hergen Spits
Journal:  J Exp Med       Date:  2010-02-08       Impact factor: 14.307

Review 10.  Roles of embryonic and adult lymphoid tissue inducer cells in primary and secondary lymphoid tissues.

Authors:  Mi-Yeon Kim
Journal:  Yonsei Med J       Date:  2008-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.